Explain hypothyroidism

Reading File
Finding Sources
Searching Images

hypothyroidism clinical features symptoms signs

This clinical photograph shows a front-view extraoral assessment of a 38-year-old female patient exhibiting classic signs of facial myxedema and weight gain associated with uncontrolled hypothyroidism. The facial contour is noticeably rounded, presenting a 'moon face' appearance with generalized fullness and obscuration of the underlying bony jawline and malar landmarks. Key visible features include bilateral periorbital puffiness, prominent soft tissue swelling in the cheeks (buccal fat pad region), and increased subcutaneous adipose tissue in the submental and cervical areas, leading to a less defined neck-to-jaw transition. The skin appears somewhat thickened with diffuse hyperpigmentation, particularly across the malar regions. These findings are characteristic clinical manifestations of thyroid dysfunction, reflecting the systemic metabolic effects and mucopolysaccharide deposition in dermal tissues. This visual material serves as an educational reference for identifying secondary systemic symptoms during a dental or general medical examination, specifically in patients with comorbid diabetes mellitus and hypothyroidism.

This clinical photograph shows a front-view extraoral assessment of a 38-year-old female patient exhibiting classic signs of facial myxedema and weight gain associated with uncontrolled hypothyroidism. The facial contour is noticeably rounded, presenting a 'moon face' appearance with generalized fullness and obscuration of the underlying bony jawline and malar landmarks. Key visible features include bilateral periorbital puffiness, prominent soft tissue swelling in the cheeks (buccal fat pad region), and increased subcutaneous adipose tissue in the submental and cervical areas, leading to a less defined neck-to-jaw transition. The skin appears somewhat thickened with diffuse hyperpigmentation, particularly across the malar regions. These findings are characteristic clinical manifestations of thyroid dysfunction, reflecting the systemic metabolic effects and mucopolysaccharide deposition in dermal tissues. This visual material serves as an educational reference for identifying secondary systemic symptoms during a dental or general medical examination, specifically in patients with comorbid diabetes mellitus and hypothyroidism.

A series of four clinical photographs (a–d) documenting the progression of a pediatric patient with primary congenital hypothyroidism before and after treatment. Images (a) and (b) represent the patient at admission, exhibiting classic symptoms of untreated hypothyroidism: severe abdominal distension (pseudo-obstruction secondary to constipation), an umbilical hernia, generalized myxedema, and visible irritability. Facial features in (b) show macroglossia (enlarged tongue), rarefied eyebrows, and brittle, sparse hair. Images (c) and (d) depict the same patient six months after initiating levothyroxine sodium replacement therapy. These images demonstrate significant clinical improvement, including the complete resolution of abdominal distension (c) and achievement of developmental milestones, such as sitting without support (d). The comparison illustrates the systemic effects of thyroid hormone deficiency on metabolism, gastrointestinal motility, and neurodevelopmental progress in infants, as well as the efficacy of hormonal replacement.

A series of four clinical photographs (a–d) documenting the progression of a pediatric patient with primary congenital hypothyroidism before and after treatment. Images (a) and (b) represent the patient at admission, exhibiting classic symptoms of untreated hypothyroidism: severe abdominal distension (pseudo-obstruction secondary to constipation), an umbilical hernia, generalized myxedema, and visible irritability. Facial features in (b) show macroglossia (enlarged tongue), rarefied eyebrows, and brittle, sparse hair. Images (c) and (d) depict the same patient six months after initiating levothyroxine sodium replacement therapy. These images demonstrate significant clinical improvement, including the complete resolution of abdominal distension (c) and achievement of developmental milestones, such as sitting without support (d). The comparison illustrates the systemic effects of thyroid hormone deficiency on metabolism, gastrointestinal motility, and neurodevelopmental progress in infants, as well as the efficacy of hormonal replacement.

A clinical photograph displaying the frontal view of a 58-year-old male exhibiting classic signs of myxedematous facies associated with primary hypothyroidism. Notable features include bilateral periorbital edema, most pronounced in the right lower eyelid, which appears as a soft, fluid-filled swelling. The patient presents with generalized facial puffiness, particularly around the mid-face and jawline, contributing to a characteristic 'moon-like' facial contour. The skin demonstrates a yellowish, pale tonality (pallor) and a dry texture consistent with xeroderma. Additional visible findings include deep forehead wrinkling, significant skin laxity in the lower facial region, and sparse lateral eyebrows. This image serves as a clinical illustration of the cutaneous and soft tissue manifestations of severe thyroid hormone deficiency, illustrating the accumulation of glycosaminoglycans in the dermis.

A clinical photograph displaying the frontal view of a 58-year-old male exhibiting classic signs of myxedematous facies associated with primary hypothyroidism. Notable features include bilateral periorbital edema, most pronounced in the right lower eyelid, which appears as a soft, fluid-filled swelling. The patient presents with generalized facial puffiness, particularly around the mid-face and jawline, contributing to a characteristic 'moon-like' facial contour. The skin demonstrates a yellowish, pale tonality (pallor) and a dry texture consistent with xeroderma. Additional visible findings include deep forehead wrinkling, significant skin laxity in the lower facial region, and sparse lateral eyebrows. This image serves as a clinical illustration of the cutaneous and soft tissue manifestations of severe thyroid hormone deficiency, illustrating the accumulation of glycosaminoglycans in the dermis.

This clinical photograph displays a three-panel series of infants illustrating classic physical manifestations of untreated congenital primary hypothyroidism at three months of age. The first two panels focus on facial features, showing coarse facial features, puffy eyelids (periorbital edema), and a characteristic 'myxedematous' facies. Notably, the infants exhibit a flat nasal bridge, macroglossia (an enlarged, protruding tongue), and thickened skin with prominent forehead wrinkling. The third panel shows an infant with a markedly distended abdomen and a prominent umbilical hernia, another hallmark sign of the condition. Additional visible indicators include sparse hair and an overall lethargic or dull appearance. These images serve as a pedagogical example of the clinical progression of hypothyroidism in infants who missed neonatal screening, highlighting the multisystemic physical signs that accompany developmental delay and metabolic insufficiency in early infancy.

This clinical photograph displays a three-panel series of infants illustrating classic physical manifestations of untreated congenital primary hypothyroidism at three months of age. The first two panels focus on facial features, showing coarse facial features, puffy eyelids (periorbital edema), and a characteristic 'myxedematous' facies. Notably, the infants exhibit a flat nasal bridge, macroglossia (an enlarged, protruding tongue), and thickened skin with prominent forehead wrinkling. The third panel shows an infant with a markedly distended abdomen and a prominent umbilical hernia, another hallmark sign of the condition. Additional visible indicators include sparse hair and an overall lethargic or dull appearance. These images serve as a pedagogical example of the clinical progression of hypothyroidism in infants who missed neonatal screening, highlighting the multisystemic physical signs that accompany developmental delay and metabolic insufficiency in early infancy.

Searching PubMed

"hypothyroidism"[MeSH Terms] AND "diagnosis" AND "treatment"

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have comprehensive content from multiple textbooks. Let me compile the full answer.

Hypothyroidism

Definition

Hypothyroidism is a hypometabolic state resulting from circulating thyroid hormone (T3/T4) levels insufficient to meet the body's metabolic requirements. When the primary defect is in the thyroid gland itself, serum TSH rises (typically >4.12 mIU/L in adults; >10 mIU/L in overt disease).
  • Textbook of Family Medicine 9e
  • Sabiston Textbook of Surgery

Pathophysiology & the HPT Axis

The hypothalamic-pituitary-thyroid (HPT) axis regulates thyroid hormone output:
  • The hypothalamus releases TRH → stimulates anterior pituitary to release TSH → TSH stimulates thyroid follicular cells to synthesize and secrete T4 and T3
  • T3/T4 exert negative feedback on both the hypothalamus and pituitary
  • In primary hypothyroidism (>95% of cases), the defect is at the thyroid gland level: TSH rises due to loss of negative feedback
  • In secondary hypothyroidism (rare), pituitary TSH secretion fails; in tertiary (very rare), hypothalamic TRH is deficient - both give low/normal TSH with low T4
  • Costanzo Physiology 7th Edition; Sabiston Textbook of Surgery

Causes

CategoryExamples
Autoimmune (most common in iodine-replete regions)Hashimoto thyroiditis (chronic lymphocytic thyroiditis) - anti-TPO and anti-thyroglobulin antibodies destroy thyroid stroma
DietaryIodine deficiency (most common worldwide)
IatrogenicThyroidectomy, radioactive iodine (RAI) treatment, head/neck radiation
Drug-inducedLithium (overt hypothyroidism in 14-17% of users; subclinical in 19-55%), amiodarone
CongenitalCretinism - absent/dysgenetic gland, enzymatic defects
TransientPostpartum thyroiditis, subacute thyroiditis, sporadic thyroiditis
CentralPituitary failure (secondary), hypothalamic failure (tertiary)
  • Rosen's Emergency Medicine; Textbook of Family Medicine 9e; Sabiston Textbook of Surgery
Hashimoto thyroiditis deserves special mention: it is predominantly a disease of females (F:M ratio 10-14:1), typically diagnosed in the fifth decade, and is progressive - antibodies (especially anti-TPO) attack the thyroidal stroma, causing fibrosis and progressive loss of T4 output. First-degree relatives carry a ninefold increased risk.

Clinical Features

The classic presentation reflects a systemic slowing of metabolism. Severity ranges from subclinical (asymptomatic) to the life-threatening extreme of myxedema coma.

Symptoms & Signs

SystemFeatures
GeneralFatigue, lethargy, weight gain, cold intolerance
CardiovascularBradycardia, decreased cardiac output, pericardial effusion, diastolic hypertension
SkinDry, coarse skin; non-pitting edema (myxedema due to glycosaminoglycan deposition); hair loss; sparse lateral eyebrows
NeurologicalMental slowness, depression, memory impairment, carpal tunnel syndrome, peripheral neuropathy
GIConstipation, ileus
ReproductiveMenorrhagia, anovulation, infertility
MetabolicHypercholesterolemia, hyponatremia
RespiratoryHypoventilation, obstructive sleep apnoea
EyesPeriorbital puffiness, drooping eyelids
PaediatricGrowth retardation; if congenital/perinatal: irreversible intellectual disability (cretinism), macroglossia, umbilical hernia
  • Sabiston Textbook of Surgery; Costanzo Physiology 7th Edition
Here is how myxedematous facies appears clinically:
Myxedematous facies - periorbital puffiness, dry skin, sparse eyebrows
Congenital hypothyroidism - macroglossia, umbilical hernia, myxedema before and after levothyroxine

Diagnosis

  • TSH is the single most sensitive screening test for primary hypothyroidism. TSH >4.12 mIU/L raises suspicion; TSH >10 mIU/L with low free T4 = overt primary hypothyroidism
  • Free T4 (fT4): low in overt hypothyroidism; normal in subclinical hypothyroidism
  • TPO antibodies: confirm autoimmune (Hashimoto) etiology
  • Central hypothyroidism: low/normal TSH + low fT4 - fT4 is the monitoring parameter (TSH is unreliable)
  • TSH should be rechecked every 6-8 weeks after starting treatment until stable, then annually
  • Sabiston Textbook of Surgery; Scott-Brown's Otorhinolaryngology
PatternDiagnosis
TSH high, fT4 lowOvert primary hypothyroidism
TSH high, fT4 normalSubclinical hypothyroidism
TSH low/normal, fT4 lowCentral (secondary/tertiary) hypothyroidism

Treatment

Levothyroxine (LT4) - First-Line

  • LT4 (synthetic T4) is the preferred first-line therapy. The body's peripheral deiodinases convert T4 to active T3 in tissues
  • Adult replacement dose: 1.6 µg/kg/day orally
  • Starting dose for subclinical/mild disease: typically 50-75 µg/day
  • Take at bedtime or 60 minutes before breakfast for optimal absorption
  • Treatment is indicated for: all overt hypothyroidism; subclinical hypothyroidism with TSH >10 mIU/L; symptomatic subclinical hypothyroidism with TSH 5.1-10 mIU/L
  • Monitoring: TSH every 6-8 weeks until stable, then annually; target TSH within normal range (typically 1-4 mIU/L)
  • Rosen's Emergency Medicine; Textbook of Family Medicine 9e

Combination T4 + T3 / Other Options

  • Multiple RCTs have not shown superiority of LT4 + liothyronine (LT3) combination over LT4 monotherapy for most patients
  • Can be tried in patients with persistent symptoms on adequate LT4 monotherapy (maintaining TSH >1.0 mIU/L to avoid iatrogenic hyperthyroidism)
  • LT3 monotherapy and desiccated thyroid extract (DTE) have limited supportive evidence; not recommended as routine first-line therapy
  • Sabiston Textbook of Surgery

Subclinical Hypothyroidism

Defined as TSH above the upper reference limit with normal fT4, in a patient who is typically asymptomatic. Whether to treat is debated:
  • TSH >10 mIU/L: treat
  • TSH 5-10 mIU/L: treat if symptomatic, or if pregnant, or if anti-TPO positive with progressive rise in TSH

Myxedema Coma

The most severe, life-threatening form of hypothyroidism. Precipitated by acute stressors (infection, trauma, surgery, drugs). Key features include:
  • Altered consciousness / coma
  • Hypothermia
  • Bradycardia, hypotension, shock
  • Hypoventilation, respiratory failure
  • Hyponatremia
  • Cardiomegaly, pericardial effusion, ascites
Emergency management:
  1. Airway protection and ventilatory support
  2. IV thyroid hormone: LT4 200-400 µg IV loading dose (lower for elderly, CAD, arrhythmia), then 1.6 µg/kg/day
  3. Hydrocortisone 100 mg IV q8h - given empirically for possible concomitant adrenal insufficiency before thyroid hormone (to prevent precipitating adrenal crisis)
  4. Fluid resuscitation (normal saline; avoid hypotonic fluids)
  5. Passive rewarming
  6. Treat the precipitating cause
  • Rosen's Emergency Medicine

Special Situations

Pregnancy: TSH targets are trimester-specific and lower than non-pregnant. ATA recommends LT4 for all pregnant women with TSH above trimester-specific upper limit + low fT4, or TSH >10 mIU/L regardless of fT4. Untreated hypothyroidism in pregnancy risks miscarriage, preeclampsia, and fetal neurodevelopmental impairment. - Tietz Textbook of Laboratory Medicine
Drug-induced (Lithium): Lithium inhibits TSH and T3 release. If symptomatic, LT4 replacement is indicated. - Kaplan and Sadock's Synopsis of Psychiatry

Recent Evidence

A 2025 systematic review/meta-analysis on quality of life in overt hypothyroidism (PMID: 40911397) highlights that many patients continue to report impaired quality of life even on levothyroxine therapy, reinforcing interest in combination therapy research. A 2024 meta-analysis (PMID: 39356749) links thyroid disease (including hypothyroidism) with sensorineural hearing loss.

Summary table:
FeatureDetail
Most common cause (developed world)Hashimoto thyroiditis
Most common cause (worldwide)Iodine deficiency
Best screening testSerum TSH
First-line treatmentLevothyroxine (T4) 1.6 µg/kg/day
MonitoringTSH (primary); fT4 (central hypothyroidism)
Emergency formMyxedema coma - IV T4 + hydrocortisone
This is a shared conversation. Sign in to Orris to start your own chat.